Exploració per autor "Comabella, Manuel"
Ara es mostren els items 1-4 de 4
-
Classification of multiple sclerosis clinical forms by 1H magnetic ressonance spectroscopy of cerebrospinal fluid
Aymerich Martínez, Francisco Javier; Alonso, Julio; Comabella, Manuel; Cabañas, Miquel; Tintoré, Maria del Mar; Montalbán, Xavier; Rovira, Àlex (2010)
Comunicació de congrés
Accés obert -
Measures in the first year of therapy predict the response to interferon beta in MS
Montalbán, Xavier; Aymerich Martínez, Francisco Javier; Río, Jordi; Castillo, J.; Rovira, Àlex; Tintoré, Maria del Mar; Sastre-Garriga, Jaume; Horga, Alex; Nos, Carlos; Comabella, Manuel (2009-07)
Article
Accés restringit per política de l'editorialSeveral criteria for treatment response to interferon beta (IFNβ) have been proposed, although there is no consensus among different investigators. Hence, the aim of this study was to investigate magnetic resonance imaging ... -
MRI phenotypes with high neurodegeneration are associated with peripheral blood B-cell changes
Comabella, Manuel; Cantó, Ester; Nurtdinov, Ramil; Río, Jordi; Villar, Luisa M.; Picón, Carmen; Castilló, Joaquin; Fissolo, Nicolás; Aymerich Martínez, Francisco Javier; Auger, Cristina; Rovira, Alex; Montalban, Xavier (2016-01)
Article
Accés obert -
Serum neurofilament light chain levels predict long-term disability progression in patients with progressive multiple sclerosis
Comabella, Manuel; Sastre Garriga, Jaume; Carbonell Mirabent, Pere; Fissolo, Nicolás; Tur, Carmen; Malhotra, Sunny; Pareto Onghena, Deborah; Aymerich Martínez, Francisco Javier; Río, Jordi; Rovira, Alex; Tintoré, Mar; Montalban, Xavier (2022-01-01)
Article
Accés obertObjective : There is a lack of sensitive and specific biomarkers for use in progressive multiple sclerosis (MS). The study aimed to assess the potential of serum neurofilament light chain (sNfL) levels as biomarker of ...